NYSEMKT: IBO
Impact Biomedical Revenue

Impact Biomedical revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IBO annual revenue was $0.0, with N/A growth year-over-year.

IBO past revenue growth

How has IBO's revenue growth performed historically?

Company
N/A
Industry
479.21%
Market
20.62%
IBO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IBO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

IBO revenue history

Current Revenue
$0.0
Current Earnings
-$24.7M
Current Profit Margin
0%

Be the first to know when IBO announces revenue.

IBO Revenue History By Year

IBO Yearly RevenueIBO RevenueIBO ChangeIBO Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00-$50.00k-100.00%
2022-12-31$50.00kN/AN/A

1 of 1

Impact Biomedical Revenue FAQ

What was IBO's revenue last quarter?

Impact Biomedical (NYSEMKT: IBO) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Impact Biomedical's revenue was $0.00.

What was Impact Biomedical's revenue in 2024?

Impact Biomedical's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Impact Biomedical make in a day?

Based on Impact Biomedical annual revenue for the past two years, IBO makes an average of $0.00 per day.

What was Impact Biomedical's annual revenue growth in the past year?

As of Q2 2025, Impact Biomedical's revenue has grown null year over year. Impact Biomedical's revenue in the past year totaled $0.00.

How much does Impact Biomedical make in a year?

Impact Biomedical's revenue by year for the past two years is:
  • Impact Biomedical's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Impact Biomedical's annual revenue for Dec 31, 2023 was $0.00, a 100% decrease from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.